PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

High Potential for the Immune and Antihypertensive Health Ingredients Market in Europe Finds Frost & Sullivan - Spirited R&D efforts to support efficacy can ramp up market prospects
High Potential for the Immune and Antihypertensive Health Ingredients Market in Europe Finds Frost & Sullivan

 

NewswireToday - /newswire/ - London, United Kingdom, 2011/09/13 - Spirited R&D efforts to support efficacy can ramp up market prospects.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The rising incidence of problems related to high blood pressure and weak immune system as well as the gravitation toward preventive healthcare is driving the European market for nutritional solutions in immune and antihypertensive health. The swine flu epidemic that hit Europe and the United States is one of the factors that boosted consumer interest in maintaining a healthy immune system.

Ingredients manufacturers in this space are cashing in on the growing awareness of the potential of immune health ingredients in preventing flu-like symptoms and respiratory infections. In particular, health ingredients that offer cholesterol- and blood pressure-lowering benefits are poised to pick up traction. Although blood pressure lowering ingredients are not currently very popular, they are expected to slowly catch up due to improving consumer awareness.

New analysis from Frost & Sullivan (chemicals.frost.com), European Market for Nutritional Solutions in Immune and Antihypertensive Health, finds that the market earned revenues of $577.9 million in 2009 and estimates this to reach $838.6 million in 2016.

"The sheer extent at which cardiovascular disease (CVD) affects the population in Europe, including those with hypertension, offers significant opportunities for ingredient manufacturers," says Frost & Sullivan Senior Research Analyst Sneha Pasricha.

However, the preference for traditional modes of lowering blood pressure such as exercise, weight management, salt reduction, and drugs such as diuretics, beta-blockers, angiotensive converting enzyme (ACE) inhibitors, calcium channel blockers or vasodilators is hindering market momentum.

Similarly, immune health ingredients segment is faced with the challenge of rigorous competition that is prevalent among the plethora of such ingredients available in the market. Most of these ingredients are positioned for other health benefits as well. For instance, probiotics and prebiotics are projected primarily as providers of digestive health benefits rather than positive immune health advantages. Such a scenario creates confusion in the minds of consumers and dissuades them from buying such ingredients.

"Besides, regulatory issues pertaining to health claims are limiting innovation and growth in the European Market for Nutritional Solutions in Immune and Antihypertensive Health, like any other health ingredient market in the region," notes Pasricha. "Health claim regulations in Europe are getting increasingly complex and vague with the Nutrition and Health Claims Regulation adopted in 2006."

Steps by European Food Safety Agency (EFSA) directed at bringing clarity on the criteria required for positive scientific opinion from the organisation with respect to health claims is likely to encourage innovation in the market.

"Manufacturers must make efforts to ramp up awareness levels among consumers about the scientific-backing and the mode of action of their immune and anti-hypertensive health ingredients," says Pasricha. "Proactive research initiatives by manufacturers supporting their ingredients efficacy, empowered with apt promotional efforts could prove instrumental in increasing consumer/customer trust and acceptance."

If you are interested in more information on this study, please send an e-mail with your contact details to Chiara Carella, Corporate Communications, at chiara.carella[.]frost.com.

European Market for Nutritional Solutions in Immune and Antihypertensive Health is part of the Chemicals & Materials Growth Partnership Service program, which also includes research in the following markets: Trends and Opportunities in the European Protein Ingredients Market, European Market for Enzymes in Food Application, European Digestive Ingredients in Animal Feed Market, and U.S. Digestive Ingredients in Animal Feed Market. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents. To join our Growth Partnership, please visit frost.com.

European Market for Nutritional Solutions in Immune and Antihypertensive Health / M5C5

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


High Potential for the Immune and Antihypertensive Health Ingredients Market in Europe Finds Frost & Sullivan

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan |
Publisher Contact: Chiara Carella 
+44(0)20 7343 8314 chiara.carella[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  Triggr & Bloom





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)